CWIR yields 20000000.00% · JNJ yields 2.13%● Live data
📍 CWIR pulled ahead of the other in Year 1
Combined, CWIR + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CWIR + JNJ for your $10,000?
Central Wireless, Inc., a development stage company, operates as a wireless communications infrastructure company. It primarily engages in the design, engineering, development, and construction of towers for the transmission of broadband, cellular, and other wireless communications signals. These towers include the monopole, the guy tower, stealth tower designs, and self-support towers, and broadcast telecommunications signals for personal communications services, cellular, wireless data, paging, and broadcast technologies. The company also provides related services, including site acquisition, zoning, and antennae and line installation. It also offers various consulting services, including lease negotiation and assistance in regulatory matters. The company's customers primarily include broadband and other wireless telecommunications carriers, and individuals or businesses that desire to lease or own telecommunications towers. It principally operates in the greater Sarasota, Florida region; Oklahoma; and Minnesota in the United States. Central Wireless, Inc. is based in Las Vegas, Nevada.
Full CWIR Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.